Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss

Articles From: Pioneer Energy Services Announces First Quarter 2013 Earnings Release and Conference Call Schedule to Bayer to Acquire Conceptus to Bolster Contraceptive Business

This site contains about 63,386 documents.
View by:
Title  |  Date  |  Author  |  Collection  |  Interest  |  Popularity
Page:   1   600   700   800   900   1,000   1,100   1,200   1,300   1,400   1,550   1,560   1,570   1,580   1,590   1,600   1,610   1,620   1,630   1,640   1,641   1,642   1,643   1,644   1,645   1,646   1,647   1,648   1,649   1,650   1,651   1,652   1,653   1,654   1,655   1,656   1,657   1,658   1,659   1,660   1,661   1,662   1,663   1,664   1,665   1,666   1,667   1,668   1,669   1,670   1,680   1,690   1,700   1,710   1,720   1,730   1,740   1,750   1,800   1,900   2,000   2,100   2,113 

2013/4/29
Pioneer Energy Services Announces First Quarter 2013 Earnings Release and Conference Call Schedule
SAN ANTONIO , April 29, 2013 /PRNewswire/ -- Pioneer Energy Services (NYSE: PES) today announced that it will release its first quarter 2013 financial results before the market opens on Tuesday, April 30.
View more Pioneer Energy Services Announces First Quarter 2013 Earnings Release and Conference Call Schedule analysis
Sign-up for Pioneer Energy Services Announces First Quarter 2013 Earnings Release and Conference Call Schedule investment picks
2013/4/29
pSivida Reports ILUVIEN® Available in UK
pSivida Corp.
View more pSivida Reports ILUVIEN® Available in UK analysis
Sign-up for pSivida Reports ILUVIEN® Available in UK investment picks
2013/4/29
Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013
JERUSALEM , April 29, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ), a developer of oral delivery systems of drugs currently administered by injection, announced today that its abstract, entitled "Oral insulin capsules toward management of Type 1 diabetes mellitus," will be presented at the Global Technology Community Diabetes Summit 2013.
View more Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013 analysis
Sign-up for Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013 investment picks
2013/4/29
Rent-A-Center Announces Intention to Offer $250 Million in Senior Unsecured Notes
Rent-A-Center, Inc. (the “Company”) (NASDAQ/NGS: RCII) announced today that it intends, subject to market conditions, to offer $250 million in aggregate principal amount of senior unsecured notes due 2021 (the “notes”) in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The Company intends to use the net proceeds of the offering to repay $46 million of the revolving loans outstanding under its revolving credit facility and apply the remainder to accelerated common stock repurchases as market conditions permit and, to the extent not so applied, for general corporate purposes.
View more Rent-A-Center Announces Intention to Offer $250 Million in Senior Unsecured Notes analysis
Sign-up for Rent-A-Center Announces Intention to Offer $250 Million in Senior Unsecured Notes investment picks
2013/4/29
Luxottica CEO Sees "Good" Growth in 2013 as Sunglass Use Grows
MILAN --
View more Luxottica CEO Sees "Good" Growth in 2013 as Sunglass Use Grows analysis
Sign-up for Luxottica CEO Sees "Good" Growth in 2013 as Sunglass Use Grows investment picks
2013/4/29
Penske Automotive Reports Record Results
Penske Automotive Group, Inc. (NYSE:PAG) , an international automotive retailer, announced today the highest income and earnings per share in company history.
View more Penske Automotive Reports Record Results analysis
Sign-up for Penske Automotive Reports Record Results investment picks
2013/4/29
Eaton 1st-Quarter Net Up 22% on Acquisition; Sales Miss Street View
Eaton Corp.'s (ETN) first-quarter earnings rose 22% with the help of its Cooper Industries acquisition, but revenue growth fell short of Wall Street views as global demand continued to slow.
View more Eaton 1st-Quarter Net Up 22% on Acquisition; Sales Miss Street View analysis
Sign-up for Eaton 1st-Quarter Net Up 22% on Acquisition; Sales Miss Street View investment picks
2013/4/29
Endeavour Silver Implements Cost Reductions, Revises 2013 Financial Plan to Reflect Lower Precious Metal Prices
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0869540001&sourceType=1 http://www.ccnmatthews.com/logos/20061115-edr2.gif VANCOUVER, BRITISH COLUMBIA --
View more Endeavour Silver Implements Cost Reductions, Revises 2013 Financial Plan to Reflect Lower Precious Metal Prices analysis
Sign-up for Endeavour Silver Implements Cost Reductions, Revises 2013 Financial Plan to Reflect Lower Precious Metal Prices investment picks
2013/4/29
Ultrapetrol Appoints New CFO
NASSAU, Bahamas, April 29, 2013 (GLOBE NEWSWIRE) -- Ultrapetrol (Bahamas) Limited (Nasdaq:ULTR) , an industrial transportation company serving marine transportation needs in three markets (River Business, Offshore Supply Business and Ocean Business), announced today the appointment of Ms.
View more Ultrapetrol Appoints New CFO analysis
Sign-up for Ultrapetrol Appoints New CFO investment picks
2013/4/29
RainDance Technologies Closes $20 Million Series E Financing
RainDance Technologies, Inc., the Digital Biology™ Company, today announced the closing of a $20 million Series E financing round.
View more RainDance Technologies Closes $20 Million Series E Financing analysis
Sign-up for RainDance Technologies Closes $20 Million Series E Financing investment picks
2013/4/29
Professional Diversity Network Announces Share Repurchase Program
CHICAGO, April 29, 2013 (GLOBE NEWSWIRE) -- Professional Diversity Network, Inc. (Nasdaq:IPDN) , a developer and operator of online networks dedicated to serving diverse professionals in the United States and providing them with access to employment opportunities, today announced that its Board of Directors has authorized a share repurchase program pursuant to which the Company may repurchase up to $1 million of its outstanding common stock.
View more Professional Diversity Network Announces Share Repurchase Program analysis
Sign-up for Professional Diversity Network Announces Share Repurchase Program investment picks
2013/4/29
Alimera Sciences Announces ILUVIEN® Now Available In U.K.
Simple Patient Access Scheme has been submitted to NICE for rapid review       ATLANTA , April 29, 2013 /PRNewswire/ -- Alimera Sciences, Inc., (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that ILUVIEN ® , the first sustained release pharmaceutical product for the treatment of chronic diabetic macular edema (DME), is now available in the United Kingdom .
View more Alimera Sciences Announces ILUVIEN® Now Available In U.K. analysis
Sign-up for Alimera Sciences Announces ILUVIEN® Now Available In U.K. investment picks
2013/4/29
DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders
QUEBEC CITY , April 29, 2013 /PRNewswire/ - DiagnoCure Inc. (TSX: CUR) (OTCQX: DGCRF) reminds shareholders to attend its Annual and Special Meeting of Shareholders to be held today, April 29 th , at 3pm EDT , at the offices of McCarthy Tetrault, 1000 de la Gauchetière Street West, Suite 2500, Montreal, Quebec , H3B 0A2.
View more DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders analysis
Sign-up for DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders investment picks
2013/4/29
DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders
DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders Canada NewsWire QUEBEC CITY, April 29, 2013 /CNW Telbec/ - DiagnoCure Inc. (TSX: CUR) (OTCQX: DGCRF) reminds shareholders to attend its Annual and Special Meeting of Shareholders to be held today, April 29 th , at 3pm EDT , at the offices of McCarthy Tetrault, 1000 de la Gauchetière Street West, Suite 2500, Montreal , Quebec , H3B 0A2.
View more DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders analysis
Sign-up for DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders investment picks
2013/4/29
Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes
Merck & Co., Inc. (NYSE: MRK) , known as MSD outside the United States and Canada (“Merck”), and Pfizer Inc. (NYSE:PFE) today announced that they have entered into a worldwide (except Japan) collaboration agreement for the development and commercialization of Pfizer’s ertugliflozin (PF-04971729), an investigational oral sodium glucose cotransporter (SGLT2) inhibitor being evaluated for the treatment of type 2 diabetes.
View more Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes analysis
Sign-up for Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes investment picks
2013/4/29
Stonegate Agricom to Issue Common Shares to Sprott Resource Corp. for Debt
Stonegate Agricom to Issue Common Shares to Sprott Resource Corp.
View more Stonegate Agricom to Issue Common Shares to Sprott Resource Corp. for Debt analysis
Sign-up for Stonegate Agricom to Issue Common Shares to Sprott Resource Corp. for Debt investment picks
2013/4/29
Abengoa to develop cogeneration plant in Texas
- The cogeneration plant is expected to generate 15 megawatts (MW) of electricity.
View more Abengoa to develop cogeneration plant in Texas analysis
Sign-up for Abengoa to develop cogeneration plant in Texas investment picks
2013/4/29
Cominar announces the addition of Gilles Hamel as Vice-President Corporate Finance and Administration
Cominar announces the addition of Gilles Hamel as Vice-President Corporate Finance and Administration Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE U.S./ QUÉBEC CITY, April 29, 2013 /CNW Telbec/ - Cominar Real Estate Investment Trust ("Cominar") (TSX: CUF.UN) announces today that on July 1, 2013 Mr.
View more Cominar announces the addition of Gilles Hamel as Vice-President Corporate Finance and Administration analysis
Sign-up for Cominar announces the addition of Gilles Hamel as Vice-President Corporate Finance and Administration investment picks
2013/4/29
Phase I Data Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Weekly Doses of Dalbavancin Presented at the 23rd Annual ECCMID Meeting
CHICAGO, April 29, 2013 (GLOBE NEWSWIRE) -- Durata Therapeutics , Inc. (Nasdaq:DRTX) today announced data from a Phase 1 study of its lead product candidate, dalbavancin, under investigation for the treatment of susceptible gram positive bacterial infections including MRSA.
View more Phase I Data Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Weekly Doses of Dalbavancin Presented at the 23rd Annual ECCMID Meeting analysis
Sign-up for Phase I Data Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Weekly Doses of Dalbavancin Presented at the 23rd Annual ECCMID Meeting investment picks
2013/4/29
New Data Demonstrating In Vitro Potency of Dalbavancin Against Bacterial Pathogens Presented at the 23rd Annual ECCMID Meeting
CHICAGO, April 29, 2013 (GLOBE NEWSWIRE) -- Durata Therapeutics , Inc. (Nasdaq:DRTX) today announced data from surveillance results of its lead product candidate, dalbavancin, under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSSI). The data, presented at the 23 rd Annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), demonstrate that in vitro potency of dalbavancin remains consistent with earlier surveillance reports.
View more New Data Demonstrating In Vitro Potency of Dalbavancin Against Bacterial Pathogens Presented at the 23rd Annual ECCMID Meeting analysis
Sign-up for New Data Demonstrating In Vitro Potency of Dalbavancin Against Bacterial Pathogens Presented at the 23rd Annual ECCMID Meeting investment picks
2013/4/29
Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results on May 10, 2013
http://media.marketwire.com/attachments/201202/41133_horizon_pharma_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010932&ProfileId=051205&sourceType=1 DEERFIELD, IL --
View more Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results on May 10, 2013 analysis
Sign-up for Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results on May 10, 2013 investment picks
2013/4/29
Two Harbors Investment Corp. Announces Tax Basis Information for the Distribution of Silver Bay Realty Trust Corp. Common Stock
Two Harbors Investment Corp .
View more Two Harbors Investment Corp. Announces Tax Basis Information for the Distribution of Silver Bay Realty Trust Corp. Common Stock analysis
Sign-up for Two Harbors Investment Corp. Announces Tax Basis Information for the Distribution of Silver Bay Realty Trust Corp. Common Stock investment picks
2013/4/29
BNY Mellon Awarded Best ETF Service Provider In The Americas for Seventh Year in Row
NEW YORK , April 29, 2013 /PRNewswire/ -- BNY Mellon, the global leader in investment management and investment services, has been named as the 2012 "Best Service Provider – The Americas" at the ninth annual Global ETF Awards, which is sponsored by exchangetradedfunds.com.  This is the seventh consecutive year that BNY Mellon has been honored as the top service provider to ETFs (exchanged-traded funds). "We continue to enhance our industry-leading technology to support an ever-increasing array of ETF categories, including actively managed ETFs, commodity-linked ETFs and global ETFs," said Joseph F.
View more BNY Mellon Awarded Best ETF Service Provider In The Americas for Seventh Year in Row analysis
Sign-up for BNY Mellon Awarded Best ETF Service Provider In The Americas for Seventh Year in Row investment picks
2013/4/29
UPDATE: Bayer Agrees to Buy Conceptus for $1.1 Billion in Cash
(Adds Conceptus earnings.) --Bayer agrees to buy Conceptus for $1.1 billion --Acquisition broadens Bayer's contraceptive offerings --Separately, Conceptus reports it swung to a first-quarter profit By Saabira Chaudhuri Bayer AG (BAYRY, BAYN.XE) has agreed to buy Conceptus Inc. (CPTS) for about $1.1 billion ( 852 million euros ) as the health-care company aims to broaden its women's contraceptive offerings.
View more UPDATE: Bayer Agrees to Buy Conceptus for $1.1 Billion in Cash analysis
Sign-up for UPDATE: Bayer Agrees to Buy Conceptus for $1.1 Billion in Cash investment picks
2013/4/29
W&T Offshore Announces Increase in Borrowing Base Under Revolving Credit Facility
HOUSTON , April 29, 2013 /PRNewswire/ -- W&T Offshore, Inc. (NYSE: WTI) announced today that it has received an increase in the borrowing base under its revolving credit facility from $725 million to $800 million .
View more W&T Offshore Announces Increase in Borrowing Base Under Revolving Credit Facility analysis
Sign-up for W&T Offshore Announces Increase in Borrowing Base Under Revolving Credit Facility investment picks
2013/4/29
Allied Electronics Signs Distribution Agreement with ON Semiconductor
FORT WORTH, Texas, April 29, 2013 (GLOBE NEWSWIRE) -- Allied Electronics, a trading brand of Electrocomponents plc (LSE:ECM) , recently signed a distribution agreement with ON Semiconductor, one of the largest global semiconductor companies offering a comprehensive portfolio of energy-efficient products.
View more Allied Electronics Signs Distribution Agreement with ON Semiconductor analysis
Sign-up for Allied Electronics Signs Distribution Agreement with ON Semiconductor investment picks
2013/4/29
OATSystems, a Division of Checkpoint Systems, Providing Passive RFID Asset Tracking for Five-Year Veterans Affairs Hospital Contract
OATSystems , a division of Checkpoint Systems, Inc .
View more OATSystems, a Division of Checkpoint Systems, Providing Passive RFID Asset Tracking for Five-Year Veterans Affairs Hospital Contract analysis
Sign-up for OATSystems, a Division of Checkpoint Systems, Providing Passive RFID Asset Tracking for Five-Year Veterans Affairs Hospital Contract investment picks
2013/4/29
Micrel Signs Phoenics Electronics as Distributor
http://media.marketwire.com/attachments/201005/597776_newlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010560&ProfileId=051205&sourceType=1 SAN JOSE, CA --
View more Micrel Signs Phoenics Electronics as Distributor analysis
Sign-up for Micrel Signs Phoenics Electronics as Distributor investment picks
2013/4/29
Sinclair Broadcast Group Announces Public Offering of Class A Common Stock
BALTIMORE , April 29, 2013 /PRNewswire/ -- Sinclair Broadcast Group, Inc. ("Sinclair" or the "Company") (Nasdaq: SBGI) announced today that it has commenced an underwritten public offering of 14.0 million primary shares of Class A common stock.
View more Sinclair Broadcast Group Announces Public Offering of Class A Common Stock analysis
Sign-up for Sinclair Broadcast Group Announces Public Offering of Class A Common Stock investment picks
2013/4/29
Bayer to Acquire Conceptus to Bolster Contraceptive Business
German chemicals and pharmaceuticals group Bayer AG (BAYN.SE) said Monday it will acquire California -based Conceptus Inc. (CPTS) in a deal that values the company at $1.1 billion , to bolster its flagging contraceptives business.
View more Bayer to Acquire Conceptus to Bolster Contraceptive Business analysis
Sign-up for Bayer to Acquire Conceptus to Bolster Contraceptive Business investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
Articles From: Pioneer Energy Services Announces First Quarter 2013 Earnings Release and Conference Call Schedule to Bayer to Acquire Conceptus to Bolster Contraceptive Business
Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Mutual Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title
ETFs by:
Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name
Investment Categories by:
Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry
Premimum Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Premimum Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title
Premimum ETFs by:
Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name
Popular Articles by:
Title |  Date |  Author |  Collection |  Popularity |  Interest
SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Popular SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.